Key Highlights
- Trading in MindBio Therapeutics Corp. shares resumed on the Canadian Securities Exchange.
- The Canadian Investment Regulatory Organization set the resumption time at 11:15 am Eastern.
- The notice did not disclose the reason for the earlier trading halt.
Trading in MindBio Therapeutics Corp. (CSE: MBIO) resumed on the Canadian Securities Exchange, according to a notice published by the Canadian Investment Regulatory Organization (CIRO).
CIRO listed the resumption time as 11:15 am Eastern on Nov. 5, 2026, and indicated the resumption applied to all issues of the company.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
The CIRO notice did not provide details on why trading had been halted before the resumption.
CIRO is Canadas national self-regulatory organization overseeing investment dealers and trading activity on debt and equity marketplaces, and it can impose temporary trading halts to support a fair and orderly market.
The original press release is available on stockhouse.com
s-13v4_h-14v4_i-15v4